Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?